- 200 years
- Study
- International
- Business and employers
- Research
- About us
https://webcdn.mmu.ac.uk/profiles/img/profile-images/Jerzy-Krupinski-MMU-crop-145x145-5e286bf268285.jpg
B. Hurtado, X. Munoz, P. Recarte-Pelz, N. Garcia, A. Luque, et al. J. Krupinski, N. Sala, P. Garcia de Frutos. (2011). Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. THROMBOSIS AND HAEMOSTASIS. 105(5), pp.873-882.
A. Flores, A. Garcia-Tornel, L. Seró, X. Ustrell, M. Requena, et al. A. Pellisé, P. Rodriguez, A. Monterde, L. Lara, JM. Gonzalez-de-Echavarri, CA. Molina, A. Doncel-Moriano, L. Dorado, P. Cardona, D. Cánovas, J. Krupinski, N. Más, F. Purroy, J. Zaragoza-Brunet, E. Palomeras, D. Cocho, J. Garcia, C. Colom, Y. Silva, M. Gomez-Cocho, X. Jiménez, J. Ros-Roig, S. Abilleira, N. Pérez de la Ossa, M. Ribo, . RACECAT trial investigators. (2024). Influence of vascular imaging acquisition at local stroke centers on workflows in the drip-n-ship model: a RACECAT post hoc analysis. J Neurointerv Surg. 16(2), pp.143-150.
Y. Silva, L. Sánchez-Cirera, M. Terceño, L. Dorado, A. Valls, et al. M. Martínez, S. Abilleira, M. Rubiera, H. Quesada, L. Llull, A. Rodríguez-Campello, J. Martí-Fàbregas, L. Seró, F. Purroy, I. Payo, S. García, D. Cánovas, J. Krupinski, N. Mas, E. Palomeras, D. Cocho, MÀ. Font, E. Catena, E. Puiggròs, C. Pedroza, G. Marín, D. Carrión, X. Costa, MC. Almendros, I. Torres, C. Colom, JA. Velasquez, G. Diaz, X. Jiménez, T. Subirats, A. Deulofeu, V. Hidalgo, M. Salvat-Plana, N. Pérez de la Ossa. (2023). Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia. Eur Stroke J. 8(2), pp.557-565.
Á. García-Tornel, A. Flores, M. Terceño, P. Cardona, S. Amaro, et al. M. Gomis, J. Zaragoza, J. Krupinski, M. Gómez-Choco, N. Mas, D. Cocho, E. Catena, F. Purroy, M. Deck, M. Rubiera, J. Pagola, D. Rodriguez-Luna, J. Juega, N. Rodríguez-Villatoro, CA. Molina, C. Soro, X. Jimenez, M. Salvat-Plana, A. Dávalos, TG. Jovin, S. Abilleira, N. Pérez de la Ossa, M. Ribó, . RACECAT Trial Investigators. (2023). Association of Time of Day With Outcomes Among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia. Stroke. 54(3), pp.770-780.
M. Olivé-Gadea, N. Pérez de la Ossa, T. Jovin, S. Abilleira, X. Jiménez, et al. P. Cardona, A. Chamorro, A. Flores, Y. Silva, F. Purroy, J. Martí-Fabregas, A. Rodríguez-Campello, J. Zaragoza, J. Krupinski, D. Canovas, M. Gomez Choco, N. Mas, E. Palomeras, D. Cocho, JM. Aragonès, C. Repullo, E. Sanjurjo, D. Carrion, E. Catena, X. Costa, MC. Almendros, M. Barceló, J. Monedero, M. Rybyeva, G. Diaz, M. Ribó. (2023). Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population. Int J Stroke. 18(2), pp.229-236.
D. Campo-Caballero, P. de la Riva, A. de Arce, M. Martínez-Zabaleta, J. Rodríguez-Antigüedad, et al. J. Ekiza, P. Iruzubieta, F. Purroy, B. Fuentes, M. de Lera Alfonso, J. Krupinski, JJ. Mengual Chirife, E. Palomeras, D. Guisado-Alonso, M. Rodríguez-Yáñez, X. Ustrell, J. Tejada García, A. de Felipe Mimbrera, M. Paré-Curell, J. Tembl, S. Cajaraville, M. Garcés, J. Serena. (2023). Reperfusion therapy in acute ischaemic stroke due to cervical and cerebral artery dissection: Results from a Spanish multicentre study. Neurologia (Engl Ed). 38(6), pp.412-418.
A. Garcia-Tornel, M. Millan, M. Rubiera, A. Bustamante, M. Requena, et al. L. Dorado, M. Olivé-Gadea, X. Jiménez, A. Soto, M. Querol, M. Hernández-Pérez, M. Gomis, P. Cardona, X. Urra, F. Purroy, Y. Silva, X. Ustrell, P. Esteve, M. Salvat-Plana, M. Gallofré, C. Molina, A. Dávalos, T. Jovin, S. Abilleira, M. Ribo, N. Pérez de la Ossa, . RACECAT Trial Investigators. (2022). Workflows and Outcomes in Patients With Suspected Large Vessel Occlusion Stroke Triaged in Urban and Nonurban Areas. Stroke. 53(12), pp.3728-3740.
Á. García-Tornel, L. Seró, X. Urra, P. Cardona, J. Zaragoza, et al. J. Krupinski, M. Gómez-Choco, NM. Sala, E. Catena, E. Palomeras, J. Serena, M. Hernandez-Perez, S. Boned, M. Olivé-Gadea, M. Requena, M. Muchada, A. Tomasello, CA. Molina, M. Salvat-Plana, M. Escudero, X. Jimenez, A. Davalos, TG. Jovin, F. Purroy, S. Abilleira, M. Ribo, NP. de la Ossa, . RACECAT trial investigators. (2022). Workflow Times and Outcomes in Patients Triaged for a Suspected Severe Stroke. Ann Neurol. 92(6), pp.931-942.
MÀ. Font, SM. García-Sánchez, JJ. Mengual, L. Mena, C. Avellaneda, et al. J. Serena, A. Valls-Carbó, Á. Chamorro, X. Ustrell, C. Molina, P. Cardona, M. Guasch-Jiménez, F. Purroy, A. Rodríguez-Campello, E. Palomeras, D. Cocho, J. Krupinski, D. Cánovas, J. García-Alhama, J. Zaragoza, E. Puiggròs, N. Matos, JM. Aragonès, X. Costa, E. Sanjurjo, C. Pedroza, J. Monedero, MC. Almendros, M. Rybyeva, D. Carrión, G. Díaz, M. Barceló, X. Jiménez-Fàbrega, M. Salvat-Plana, R. Elosúa, N. Pérez de la Ossa, M. Gómez-Choco, . Catalan Stroke Code and Reperfusion Consortium (Cat-SCR Consortium). (2022). Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020. Stroke. 53(11), pp.3289-3294.
N. Cullell, C. Soriano-Tárraga, C. Gallego-Fábrega, J. Cárcel-Márquez, NP. Torres-Águila, et al. E. Muiño, M. Lledós, L. Llucià-Carol, M. Esteller, M. Castro de Moura, J. Montaner, A. Fernández-Sanlés, R. Elosua, P. Delgado, J. Martí-Fábregas, J. Krupinski, J. Roquer, J. Jiménez-Conde, I. Fernández-Cadenas. (2022). DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study. Thromb Haemost. 122(10), pp.1767-1778.
C. Gallego-Fabrega, E. Muiño, N. Cullell, J. Cárcel-Márquez, U. Lazcano, et al. C. Soriano-Tárraga, M. Lledós, L. Llucià-Carol, A. Aguilera-Simón, R. Marín, L. Prats-Sánchez, P. Camps-Renom, R. Delgado-Mederos, JM. Martín-Campos, P. Delgado, J. Martí-Fàbregas, J. Montaner, J. Krupinski, J. Jiménez-Conde, J. Roquer, I. Fernández-Cadenas. (2022). Biological Age Acceleration Is Lower in Women With Ischemic Stroke Compared to Men. Stroke. 53(7), pp.2320-2330.
N. Cullell, J. Cárcel-Márquez, C. Gallego-Fábrega, E. Muiño, L. Llucià-Carol, et al. M. Lledós, KEU. Amaut, J. Krupinski, I. Fernández-Cadenas. (2021). Sleep/wake cycle alterations as a cause of neurodegenerative diseases: A Mendelian randomization study. Neurobiol Aging. 106, pp.320.e1-320.e12.
J. Cárcel-Márquez, N. Cullell, E. Muiño, C. Gallego-Fabrega, M. Lledós, et al. L. Ibañez, J. Krupinski, J. Montaner, C. Cruchaga, J-M. Lee, D. Gill, G. Paré, M. Mola-Caminal, J. Roquer, J. Jimenez-Conde, J. Martí-Fàbregas, I. Fernandez-Cadenas. (2021). Causal Effect of MMP-1 (Matrix Metalloproteinase-1), MMP-8, and MMP-12 Levels on Ischemic Stroke: A Mendelian Randomization Study. Stroke. 52(7), pp.e316-e320.
L. Heitsch, L. Ibanez, C. Carrera, MM. Binkley, D. Strbian, et al. T. Tatlisumak, A. Bustamante, M. Ribó, C. Molina, A. Dávalos, E. López-Cancio, L. Muñoz-Narbona, C. Soriano-Tárraga, E. Giralt-Steinhauer, V. Obach, A. Slowik, J. Pera, K. Lapicka-Bodzioch, J. Derbisz, T. Sobrino, J. Castillo, F. Campos, E. Rodríguez-Castro, S. Arias-Rivas, T. Segura, G. Serrano-Heras, C. Vives-Bauza, R. Díaz-Navarro, S. Tur, C. Jimenez, J. Martí-Fàbregas, R. Delgado-Mederos, J. Arenillas, J. Krupinski, N. Cullell, NP. Torres-Aguila, E. Muiño, J. Cárcel-Márquez, F. Moniche, JA. Cabezas, AL. Ford, R. Dhar, J. Roquer, P. Khatri, J. Jiménez-Conde, I. Fernandez-Cadenas, J. Montaner, J. Rosand, C. Cruchaga, J-M. Lee, . International Stroke Genetics Consortium. (2021). Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome. Stroke. 52(1), pp.132-141.
A. Ramos-Pachón, Á. García-Tornel, M. Millán, M. Ribó, S. Amaro, et al. P. Cardona, J. Martí-Fàbregas, J. Roquer, Y. Silva, X. Ustrell, F. Purroy, M. Gómez-Choco, J. Zaragoza-Brunet, D. Cánovas, J. Krupinski, NM. Sala, E. Palomeras, D. Cocho, L. Redondo, C. Repullo, E. Sanjurjo, D. Carrión, M. López, MC. Almendros, M. Barceló, J. Monedero, E. Catena, M. Rybyeba, G. Diaz, X. Jiménez-Fàbrega, S. Solà, V. Hidalgo, MJ. Pueyo, N. Pérez de la Ossa, X. Urra, . Catalan Stroke Code and Reperfusion Consortium (Cat-SCR). (2021). Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia. Cerebrovasc Dis. 50(5), pp.551-559.
D. Campo-Caballero, P. de la Riva, A. de Arce, M. Martínez-Zabaleta, J. Rodríguez-Antigüedad, et al. J. Ekiza, P. Iruzubieta, F. Purroy, B. Fuentes, M. de Lera Alfonso, J. Krupinski, JJ. Mengual Chirife, E. Palomeras, D. Guisado-Alonso, M. Rodríguez-Yáñez, X. Ustrell, J. Tejada García, A. de Felipe Mimbrera, M. Paré-Curell, J. Tembl, S. Cajaraville, M. Garcés, J. Serena. (2020). Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study. Neurologia (Engl Ed). 38(6), pp.412-418.
A. Flores, X. Ustrell, L. Seró, A. Pellisé, P. Rodriguez, et al. J. Viñas, M. Ribó, J. Krupinski, N. Más, S. Garcia, E. Palomeras Soler, D. Cocho, D. Canovas, F. Purroy, J. Serena, J. Zaragoza-Brunet, V. Obach, N. Perez de la Ossa, P. Cardona, CA. Molina, S. Abilleira, M. Rubiera, . Catalan Stroke Code and Reperfusion Consortium. (2020). Vascular Occlusion Evolution in Endovascular Reperfusion Candidates Transferred from Primary to Comprehensive Stroke Centers. Cerebrovasc Dis. 49(5), pp.550-555.
NP. Torres-Aguila, C. Carrera, AK. Giese, N. Cullell, E. Muiño, et al. J. Cárcel-Márquez, C. Gallego-Fabrega, J. González-Sánchez, M. Del Mar Freijo, J. Álvarez-Sabín, C. Molina, M. Ribó, J. Jimenez-Conde, J. Roquer, T. Sobrino, F. Campos, J. Castillo, L. Muñoz-Narbona, E. Lopez-Cancio, A. Dàvalos, R. Diaz-Navarro, S. Tur, C. Vives-Bauza, G. Serrano-Heras, T. Segura, J. Krupinski, R. Delgado-Mederos, J. Martí-Fàbregas, L. Heitsch, L. Ibañez, C. Cruchaga, NS. Rost, J. Montaner, JM. Lee, I. Fernandez-Cadenas. (2019). Genome-wide association study of white blood cell counts in patients with ischemic stroke. Stroke. 50(12), pp.3618-3621.
D. Carrera, M. Gorchs, M. Querol, S. Abilleira, M. Ribó, et al. M. Millán, A. Ramos, P. Cardona, X. Urra, A. Rodríguez-Campello, L. Prats-Sánchez, F. Purroy, J. Serena, D. Cánovas, J. Zaragoza-Brunet, JA. Krupinski, X. Ustrell, J. Saura, S. García, MÀ. Mora, X. Jiménez, A. Dávalos, N. Pérez de la Ossa, . Catalan Stroke Code and Reperfusion Consortium (Cat-SCR). (2019). Revalidation of the RACE scale after its regional implementation in Catalonia: a triage tool for large vessel occlusion. J Neurointerv Surg. 11(8), pp.751-756.
R. Malik, G. Chauhan, M. Traylor, M. Sargurupremraj, Y. Okada, et al. A. Mishra, L. Rutten-Jacobs, A-K. Giese, SW. van der Laan, S. Gretarsdottir, CD. Anderson, M. Chong, HHH. Adams, T. Ago, P. Almgren, P. Amouyel, H. Ay, TM. Bartz, OR. Benavente, S. Bevan, GB. Boncoraglio, RD. Brown, AS. Butterworth, C. Carrera, CL. Carty, DI. Chasman, W-M. Chen, JW. Cole, A. Correa, I. Cotlarciuc, C. Cruchaga, J. Danesh, PIW. de Bakker, AL. DeStefano, M. den Hoed, Q. Duan, ST. Engelter, GJ. Falcone, RF. Gottesman, RP. Grewal, V. Gudnason, S. Gustafsson, J. Haessler, TB. Harris, A. Hassan, AS. Havulinna, SR. Heckbert, EG. Holliday, G. Howard, F-C. Hsu, HI. Hyacinth, MA. Ikram, E. Ingelsson, MR. Irvin, X. Jian, J. Jiménez-Conde, JA. Johnson, JW. Jukema, M. Kanai, KL. Keene, BM. Kissela, DO. Kleindorfer, C. Kooperberg, M. Kubo, LA. Lange, CD. Langefeld, C. Langenberg, LJ. Launer, J-M. Lee, R. Lemmens, D. Leys, CM. Lewis, W-Y. Lin, AG. Lindgren, E. Lorentzen, PK. Magnusson, J. Maguire, A. Manichaikul, PF. McArdle, JF. Meschia, BD. Mitchell, TH. Mosley, MA. Nalls, T. Ninomiya, MJ. O'Donnell, BM. Psaty, SL. Pulit, K. Rannikmäe, AP. Reiner, KM. Rexrode, K. Rice, SS. Rich, PM. Ridker, NS. Rost, PM. Rothwell, JI. Rotter, T. Rundek, RL. Sacco, S. Sakaue, MM. Sale, V. Salomaa, BR. Sapkota, R. Schmidt, CO. Schmidt, U. Schminke, P. Sharma, A. Slowik, CLM. Sudlow, C. Tanislav, T. Tatlisumak, KD. Taylor, VNS. Thijs, G. Thorleifsson, U. Thorsteinsdottir, S. Tiedt, S. Trompet, C. Tzourio, CM. van Duijn, M. Walters, NJ. Wareham, S. Wassertheil-Smoller, JG. Wilson, KL. Wiggins, Q. Yang, S. Yusuf, . AFGen Consortium, . Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium, . International Genomics of Blood Pressure (iGEN-BP) Consortium, . INVENT Consortium, . STARNET, JC. Bis, T. Pastinen, A. Ruusalepp, EE. Schadt, S. Koplev, JLM. Björkegren, V. Codoni, M. Civelek, NL. Smith, DA. Trégouët, IE. Christophersen, C. Roselli, SA. Lubitz, PT. Ellinor, ES. Tai, JS. Kooner, N. Kato, J. He, P. van der Harst, P. Elliott, JC. Chambers, F. Takeuchi, AD. Johnson, . BioBank Japan Cooperative Hospital Group, . COMPASS Consortium, . EPIC-CVD Consortium, . EPIC-InterAct Consortium, . International Stroke Genetics Consortium (ISGC), . METASTROKE Consortium, . Neurology Working Group of the CHARGE Consortium, . NINDS Stroke Genetics Network (SiGN), . UK Young Lacunar DNA Study, . MEGASTROKE Consortium, DK. Sanghera, O. Melander, C. Jern, D. Strbian, I. Fernandez-Cadenas, WT. Longstreth, A. Rolfs, J. Hata, D. Woo, J. Rosand, G. Pare, JC. Hopewell, D. Saleheen, K. Stefansson, BB. Worrall, SJ. Kittner, S. Seshadri, M. Fornage, HS. Markus, JMM. Howson, Y. Kamatani, S. Debette, M. Dichgans. (2019). Publisher Correction: Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 51(7), pp.1192-1193.
J. Martí-Fàbregas, S. Medrano-Martorell, E. Merino, L. Prats-Sánchez, R. Marín, et al. R. Delgado-Mederos, A. Martínez-Domeño, P. Camps-Renom, E. Jiménez-Xarrié, M. Zedde, M. Gómez-Choco, L. Lara, A. Boix, A. Calleja, AM. De Arce-Borda, Y. Bravo, B. Fuentes, M. Hernández-Pérez, D. Cánovas, L. Llull, B. Zandio, M. Freijo, I. Casado-Naranjo, J. Sanahuja, D. Cocho, J. Krupinski, A. Rodríguez-Campello, E. Palomeras, A. De Felipe, M. Serrano, E. Zapata-Arriaza, J. Zaragoza-Brunet, I. Díaz-Maroto, J. Fernández-Domínguez, A. Lago, J. Maestre, M. Rodríguez-Yáñez, I. Gich, . HERO study investigators. (2019). MRI predicts intracranial hemorrhage in patients who receive long-term oral anticoagulation. Neurology. 92(21), pp.e2432-e2443.
H-C. Diener, RL. Sacco, JD. Easton, CB. Granger, RA. Bernstein, et al. S. Uchiyama, J. Kreuzer, L. Cronin, D. Cotton, C. Grauer, M. Brueckmann, M. Chernyatina, G. Donnan, JM. Ferro, M. Grond, B. Kallmünzer, J. Krupinski, B-C. Lee, R. Lemmens, J. Masjuan, M. Odinak, JL. Saver, PD. Schellinger, D. Toni, K. Toyoda, . RE-SPECT ESUS Steering Committee and Investigators. (2019). Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 380(20), pp.1906-1917.
M. Mola-Caminal, C. Carrera, C. Soriano-Tárraga, E. Giralt-Steinhauer, RM. Díaz-Navarro, et al. S. Tur, C. Jiménez, A. Medina-Dols, N. Cullell, NP. Torres-Aguila, E. Muiño, A. Rodríguez-Campello, A. Ois, E. Cuadrado-Godia, RM. Vivanco-Hidalgo, M. Hernandez-Guillamon, M. Solé, P. Delgado, A. Bustamante, T. García-Berrocoso, M. Mendióroz, M. Castellanos, J. Serena, J. Martí-Fàbregas, T. Segura, G. Serrano-Heras, V. Obach, M. Ribó, CA. Molina, J. Alvarez-Sabín, E. Palomeras, M. Freijo, MA. Font, J. Rosand, NS. Rost, C. Gallego-Fabrega, JM. Lee, L. Heitsch, L. Ibanez, C. Cruchaga, CL. Phuah, R. Lemmens, V. Thijs, A. Lindgren, J. Maguire, K. Rannikmae, CL. Sudlow, C. Jern, TM. Stanne, E. Lorentzen, L. Muñoz-Narbona, A. Dávalos, E. López-Cancio, BB. Worrall, D. Woo, SJ. Kittner, BD. Mitchell, J. Montaner, J. Roquer, J. Krupinski, X. Estivill, R. Rabionet, C. Vives-Bauzá, I. Fernández-Cadenas, J. Jimenez-Conde. (2019). PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis. Circulation Research. 124(1), pp.114-120.
F. Purroy, A. Vena, C. Forné, AM. de Arce, A. Dávalos, et al. B. Fuentes, JF. Arenillas, J. Krupinski, M. Gómez-Choco, E. Palomeras, J. Martí-Fábregas, J. Castillo, X. Ustrell, J. Tejada, J. Masjuan, M. Garcés, I. Benabdelhak, J. Serena. (2019). Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients. Cerebrovasc Dis. 47(3-4), pp.151-164.
A. Luque, A. Farwati, J. Krupinski, JM. Aran (2018). Association between low levels of serum miR-638 and atherosclerotic plaque vulnerability in patients with high-grade carotid stenosis. J Neurosurg. 131(1), pp.72-79.
R. Malik, G. Chauhan, M. Traylor, M. Sargurupremraj, Y. Okada, et al. A. Mishra, L. Rutten-Jacobs, A-K. Giese, SW. van der Laan, S. Gretarsdottir, CD. Anderson, M. Chong, HHH. Adams, T. Ago, P. Almgren, P. Amouyel, H. Ay, TM. Bartz, OR. Benavente, S. Bevan, GB. Boncoraglio, RD. Brown, AS. Butterworth, C. Carrera, CL. Carty, DI. Chasman, W-M. Chen, JW. Cole, A. Correa, I. Cotlarciuc, C. Cruchaga, J. Danesh, PIW. de Bakker, AL. DeStefano, M. den Hoed, Q. Duan, ST. Engelter, GJ. Falcone, RF. Gottesman, RP. Grewal, V. Gudnason, S. Gustafsson, J. Haessler, TB. Harris, A. Hassan, AS. Havulinna, SR. Heckbert, EG. Holliday, G. Howard, F-C. Hsu, HI. Hyacinth, MA. Ikram, E. Ingelsson, MR. Irvin, X. Jian, J. Jiménez-Conde, JA. Johnson, JW. Jukema, M. Kanai, KL. Keene, BM. Kissela, DO. Kleindorfer, C. Kooperberg, M. Kubo, LA. Lange, CD. Langefeld, C. Langenberg, LJ. Launer, J-M. Lee, R. Lemmens, D. Leys, CM. Lewis, W-Y. Lin, AG. Lindgren, E. Lorentzen, PK. Magnusson, J. Maguire, A. Manichaikul, PF. McArdle, JF. Meschia, BD. Mitchell, TH. Mosley, MA. Nalls, T. Ninomiya, MJ. O'Donnell, BM. Psaty, SL. Pulit, K. Rannikmäe, AP. Reiner, KM. Rexrode, K. Rice, SS. Rich, PM. Ridker, NS. Rost, PM. Rothwell, JI. Rotter, T. Rundek, RL. Sacco, S. Sakaue, MM. Sale, V. Salomaa, BR. Sapkota, R. Schmidt, CO. Schmidt, U. Schminke, P. Sharma, A. Slowik, CLM. Sudlow, C. Tanislav, T. Tatlisumak, KD. Taylor, VNS. Thijs, G. Thorleifsson, U. Thorsteinsdottir, S. Tiedt, S. Trompet, C. Tzourio, CM. van Duijn, M. Walters, NJ. Wareham, S. Wassertheil-Smoller, JG. Wilson, KL. Wiggins, Q. Yang, S. Yusuf, . AFGen Consortium, . Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium, . International Genomics of Blood Pressure (iGEN-BP) Consortium, . INVENT Consortium, . STARNET, JC. Bis, T. Pastinen, A. Ruusalepp, EE. Schadt, S. Koplev, JLM. Björkegren, V. Codoni, M. Civelek, NL. Smith, DA. Trégouët, IE. Christophersen, C. Roselli, SA. Lubitz, PT. Ellinor, ES. Tai, JS. Kooner, N. Kato, J. He, P. van der Harst, P. Elliott, JC. Chambers, F. Takeuchi, AD. Johnson, . BioBank Japan Cooperative Hospital Group, . COMPASS Consortium, . EPIC-CVD Consortium, . EPIC-InterAct Consortium, . International Stroke Genetics Consortium (ISGC), . METASTROKE Consortium, . Neurology Working Group of the CHARGE Consortium, . NINDS Stroke Genetics Network (SiGN), . UK Young Lacunar DNA Study, . MEGASTROKE Consortium, DK. Sanghera, O. Melander, C. Jern, D. Strbian, I. Fernandez-Cadenas, WT. Longstreth, A. Rolfs, J. Hata, D. Woo, J. Rosand, G. Pare, JC. Hopewell, D. Saleheen, K. Stefansson, BB. Worrall, SJ. Kittner, S. Seshadri, M. Fornage, HS. Markus, JMM. Howson, Y. Kamatani, S. Debette, M. Dichgans. (2018). Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 50(4), pp.524-537.
J. Krupinski, C. Carrera, E. Muiño, N. Torres, R. Al-Baradie, et al. N. Cullell, I. Fernandez-Cadenas. (2018). DNA Methylation in Stroke. Update of Latest Advances. Computational and Structural Biotechnology Journal. 16, pp.1-5.
N. Cullell, E. Muiño, C. Carrera, N. Torres, J. Krupinski, et al. I. Fernandez-Cadenas. (2017). Role of TRAF3 in neurological and cardiovascular diseases: an overview of recent studies. Biomol Concepts. 8(3-4), pp.197-202.
E. Muiño, C. Gallego-Fabrega, N. Cullell, C. Carrera, N. Torres, et al. J. Krupinski, J. Roquer, J. Montaner, I. Fernández-Cadenas. (2017). Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL. International Journal of Molecular Sciences. 18(9),
F. Purroy, A. Vena, D. Cánovas, P. Cardona, D. Cocho, et al. E. Cuadrado-Godia, A. Chamorro, A. Dávalos, M. Garcés, M. Gomis, J. Krupinski, E. Palomeras, M. Ribó, J. Roquer, M. Rubiera, J. Sanahuja, J. Saura, J. Serena, X. Ustrell, M. Vargas, I. Benabdelhak, S. Abilleira, M. Gallofré. (2017). Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis. Journal of the American Geriatrics Society. 65(9), pp.E117-E122.
S. Abilleira, C. Tebé, NP. de la Ossa, M. Ribó, P. Cardona, et al. X. Urra, E. Giralt-Steinhauer, D. Cánovas, P. Camps-Renom, M. Gallofré. (2017). Geographic dissemination of endovascular stroke thrombectomy in Catalonia within the 2011–2015 period. European Stroke Journal. 2(2), pp.163-170.
I. Fernández-Cadenas, M. Mendióroz, D. Giralt, C. Nafria, E. Garcia, et al. C. Carrera, C. Gallego-Fabrega, S. Domingues-Montanari, P. Delgado, M. Ribó, M. Castellanos, S. Martínez, M. Freijo, J. Jiménez-Conde, M. Rubiera, J. Alvarez-Sabín, CA. Molina, MA. Font, M. Grau Olivares, E. Palomeras, N. Perez De La Ossa, M. Martinez-Zabaleta, J. Masjuan, F. Moniche, D. Canovas, C. Piñana, F. Purroy, D. Cocho, I. Navas, C. Tejero, N. Aymerich, N. Cullell, E. Muiño, J. Serena, F. Rubio, A. Davalos, J. Roquer, JF. Arenillas, J. Martí-Fábregas, K. Keene, WM. Chen, B. Worrall, M. Sale, A. Arboix, J. Krupinski, J. Montaner. (2017). GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke. Stroke. 48(5), pp.1147-1153.
C. Carrera, J. Jiménez-Conde, S. Derdak, K. Rabionet, C. Vives-Bauzá, et al. C. Soriano-Tárrega, E. Giralt-Steinhauer, M. Mola-Caminal, RM. Diaz-Navarro, S. Tur, E. Muiño, C. Gallego-Fabrega, S. Beltran, J. Roquer, A. Ruiz, O. Sotolongo-Grau, J. Krupinski, JM. Lee, C. Cruchaga, P. Delgado, R. Malik, BB. Worrall, S. Seshadri, J. Montaner, I. Fernández-Cadenas. (2016). Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke. Thrombosis and Haemostasis. 116(6), pp.1165-1171.
S. Abilleira, A. Ribera, H. Quesada, M. Rubiera, M. Castellanos, et al. M. Vargas, M. Gomis, J. Krupinski, R. Delgado-Mederos, M. Gómez-Choco, E. Giralt-Steinhauer, MC. Garcia, A. Pellisé, F. Purroy, M. Garcés, M. Gallofré. (2016). Applicability of the SPAN-100 index in a prospective and contemporary cohort of patients treated with intravenous rtPA in Catalonia. Neurologia. 31(9), pp.592-598.
C. Gallego-Fabrega, C. Carrera, J-L. Reny, P. Fontana, A. Slowik, et al. J. Pera, A. Pezzini, G. Serrano-Heras, T. Segura, A-AA. Bin Dukhyil, J. Martí-Fàbregas, E. Muiño, N. Cullell, J. Montaner, J. Krupinski, I. Fernandez-Cadenas. (2016). PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients. Stroke. 47(7), pp.1926-1929.
C. Gallego-Fabrega, C. Carrera, J-L. Reny, P. Fontana, A. Slowik, et al. J. Pera, A. Pezzini, G. Serrano-Heras, T. Segura, J. Martí-Fàbregas, E. Muiño, N. Cullell, J. Montaner, J. Krupinski, I. Fernandez-Cadenas. (2016). TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke. Stroke. 47(5), pp.1180-1186.
N. Pérez de la Ossa, S. Abilleira, L. Dorado, X. Urra, M. Ribó, et al. P. Cardona, E. Giralt, J. Martí-Fàbregas, F. Purroy, J. Serena, D. Cánovas, M. Garcés, J. Krupinski, A. Pellisé, J. Saura, C. Molina, A. Dávalos, M. Gallofré, . Catalan Stroke Code and Reperfusion Consortium. (2016). Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia. Stroke. 47(5), pp.1381-1384.
C. Soriano-Tárraga, J. Jiménez-Conde, E. Giralt-Steinhauer, M. Mola-Caminal, RM. Vivanco-Hidalgo, et al. A. Ois, A. Rodríguez-Campello, E. Cuadrado-Godia, S. Sayols-Baixeras, R. Elosua, J. Roquer, . GENESTROKE Consortium. (2016). Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia. Hum Mol Genet. 25(3), pp.609-619.
I. Fernandez-Cadenas, C. Gallego-Fabrega, C. Carrera, E. Muino, A. Pezzini, et al. P. Fontana, JL. Reny, J. Krupinski, J. Montaner. (2015). A pharmacoepigenetic study identifies genes with altered methylation associated with vascular recurrence in ischemic stroke patients treated with clopidogrel. INTERNATIONAL JOURNAL OF STROKE. 10, pp.220-220.
C. Gallego-Fabrega, J. Krupinski, I. Fernandez-Cadenas, . Genestroke Consortium, Consorcio Español para el Estudio Genético del Ictus (2015). Drug resistance and secondary treatment of ischaemic stroke: The genetic component of the response to acetylsalicylic acid and clopidogrel. Neurologia. 30(9), pp.566-573.
S. Abilleira, P. Cardona, M. Ribó, M. Millán, V. Obach, et al. J. Roquer, D. Cánovas, J. Martí-Fàbregas, F. Rubio, J. Alvarez-Sabín, A. Dávalos, A. Chamorro, MA. de Miquel, A. Tomasello, C. Castaño, JM. Macho, A. Ribera, M. Gallofré, . Catalan Stroke Code and Reperfusion Consortium. (2014). Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy. Stroke. 45(4), pp.1046-1052.
C. Gallego-Fabrega, J. Krupinski, I. Fernandez-Cadenas (2014). Drug resistance and secondary treatment of ischaemic stroke: The genetic component of the response to acetylsalicylic acid and clopidogrel. Neurologia.
S. Abilleira, A. Ribera, A. Dávalos, M. Ribó, A. Chamorro, et al. P. Cardona, CA. Molina, A. Martínez-Yélamos, X. Urra, L. Dorado, J. Roquer, J. Martí-Fàbregas, L. Aja, A. Tomasello, C. Castaño, J. Blasco, D. Cánovas, M. Castellanos, J. Krupinski, L. Guimaraens, J. Perendreu, X. Ustrell, F. Purroy, M. Gómez-Choco, JJ. Baiges, D. Cocho, J. Saura, M. Gallofré, . Catalan Stroke Code and Reperfusion Consortium. (2014). Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study. Cerebrovasc Dis. 38(5), pp.328-336.
M. Slevin, M. Baldellou, E. Hill, Y. Alexander, G. McDowell, et al. C. Murgatroyd, M. Carroll, H. Degens, J. Krupinski, N. Rovira, M. Chowdhury, F. Serracino-Inglott, L. Badimon. (2014). Novel methods for accurate identification, isolation, and genomic analysis of symptomatic microenvironments in atherosclerotic arteries. Methods Mol Biol. 1135, pp.289-305.
A. Bosutti, J. Qi, R. Pennucci, D. Bolton, S. Matou, et al. K. Ali, LH. Tsai, J. Krupinski, EB. Petcu, J. Montaner, R. Al Baradie, F. Caccuri, A. Caruso, G. Alessandri, S. Kumar, C. Rodriguez, J. Martinez-Gonzalez, M. Slevin. (2013). Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia. PLoS ONE. 8(9),
S. Abilleira, H. Quesada, M. Rubiera, M. Castellanos, M. Vargas, et al. M. Gomis, J. Krupinski, R. Delgado-Mederos, M. Gomez-Choco, E. Giralt, MC. Garcia, A. Pellise, F. Purroy, M. Garces, A. Ribera, CSC. Reperfusion. (2013). VALIDATION OF THE "STROKE PROGNOSTICATION USING AGE AND NIHSS" (SPAN) INDEX IN A COHORT OF ISCHAEMIC STROKE PATIENTS TREATED WITH INTRAVENOUS THROMBOLYSIS. CEREBROVASCULAR DISEASES. 35, pp.666-666.
J. Krupinski, M. Slevin (2013). Emerging molecular targets for brain repair after stroke. Stroke Res Treat. 2013,
J. Krupinski, M. Abudawood, S. Matou-Nasri, R. Al-Baradie, EB. Petcu, et al. C. Justicia, A. Planas, D. Liu, N. Rovira, M. Grau-Slevin, J. Secades, M. Slevin. (2012). Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vasc Cell. 4(1),
A. Luque, MM. Turu, N. Rovira, JO. Juan-Babot, M. Slevin, et al. J. Krupinski. (2012). Early atherosclerotic plaques show evidence of infection by Chlamydia pneumoniae. Frontiers in Bioscience - Elite. 4 E(7), pp.2423-2432.
G. McDowell, M. Slevin, J. Krupinski (2011). Nanotechnology for the treatment of coronary in stent restenosis: A clinical perspective. Vascular Cell. 3,
B. Hurtado, X. Munoz, P. Recarte-Pelz, N. Garcia, A. Luque, et al. J. Krupinski, N. Sala, P. Garcia de Frutos. (2011). Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. THROMBOSIS AND HAEMOSTASIS. 105(5), pp.873-882.
M. Slevin, L. Badimon, M. Grau-Olivares, M. Morrison, J. Krupinski (2011). Nanotechnology as a basis for the vascular treatment of atherosclerosis. International Journal of Nanotechnology. 8(8-9), pp.618-630.
B. Hurtado, N. Abasolo, X. Munoz, N. Garcia, Y. Benavente, et al. F. Rubio, P. Garcia de Frutos, J. Krupinski, N. Sala. (2010). Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. THROMBOSIS AND HAEMOSTASIS. 104(3), pp.592-598.
M. Slevin, L. Badimon, M. Grau-Olivares, M. Ramis, J. Sendra, et al. M. Morrison, J. Krupinski. (2010). Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Mol Biosyst. 6(3), pp.444-450.
M. Slevin, S. Matou-Nasri, M. Turu, A. Luque, N. Rovira, et al. L. Badimon, S. Boluda, L. Potempa, C. Sanfeliu, N. de Vera, J. Krupinski. (2010). Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol. 20(1), pp.151-165.
A. Bosutti, R. Pennucci, S. Matou, J. Gaffney, S. Love, et al. L-H. Tsai, KP. Giese, S. Kumar, J. Krupinski, M. Slevin. (2010). P35/Cdk5: two critical players in cytoskeletal/cell junction stability in human brain endothelial cell angiogenesis. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 26, pp.S68-S68.
M. Slevin, MM. Turu, N. Rovira, A. Luque, M. Baldellou, et al. J. Krupinski, L. Badimon. (2010). Identification of a 'snapshot' of co-expressed angiogenic markers in laser-dissected vessels from unstable carotid plaques with targeted arrays. J Vasc Res. 47(4), pp.323-335.
M. Slevin, J. Krupinski (2009). A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease?. Histol Histopathol. 24(11), pp.1473-1478.
NA. Aziz, CK. Jurgens, GB. Landwehrmeyer, . EHDN Registry Study Group, WMC. van Roon-Mom, et al. GJB. van Ommen, T. Stijnen, RAC. Roos. (2009). Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. Neurology. 73(16), pp.1280-1285.
M. Slevin, C. Sanfeliu, MM. Turu, M. Grau-Olivares, I. Ferrer, et al. S. Boluda, J. Marti-Fabregas, S. Kumar, P. Kumar, J. Krupinski. (2009). B-cell translocation gene 2 is over-expressed in peri-infarct neurons after ischaemic stroke. Pathobiology. 76(3), pp.129-135.
I. Rico, A. Carvajal, MA. Font, M. Juncadella, J. Krupinski (2009). Asymptomatic Patients Undergoing Carotid Endarterectomy Present With Short-term Decline In Working Memory. STROKE. 40(4), pp.E275-E275.
M. Slevin, J. Krupinski (2009). Cyclin-dependent kinase-5 targeting for ischaemic stroke. Curr Opin Pharmacol. 9(2), pp.119-124.
M. Slevin, J. Krupinski, N. Rovira, M. Turu, A. Luque, et al. M. Baldellou, C. Sanfeliu, N. de Vera, L. Badimon. (2009). Identification of pro-angiogenic markers in blood vessels from stroked-affected brain tissue using laser-capture microdissection. BMC Genomics. 10,
C. Rodríguez, M. Slevin, R. Rodríguez-Calvo, S. Kumar, J. Krupinski, et al. T. Tejerina, J. Martínez-González. (2009). Modulation of endothelium and endothelial progenitor cell function by low-density lipoproteins: Implication for vascular repair, angiogenesis and vasculogenesis. Pathobiology. 76(1), pp.11-22.
J. Alvarez-Sabín, A. Penalba, M. Quintana, J. Krupinski, L. García-Bonilla, et al. J. Montaner. (2009). Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke. Cerebrovasc Dis. 28(4), pp.371-377.
MA. Font, A. Fernandez, A. Carvajal, C. Gamez, L. Badimon, et al. M. Slevin, J. Krupinski. (2009). Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Frontiers in Bioscience. 14(9), pp.3352-3360.
Q. Wang, W-H. Fang, J. Krupinski, S. Kumar, M. Slevin, et al. P. Kumar. (2008). Pax genes in embryogenesis and oncogenesis. J Cell Mol Med. 12(6A), pp.2281-2294.
J. Krupinski, MM. Turu, A. Luque, L. Badimon, M. Slevin (2008). Increased PrPC expression correlates with endoglin (CD105) positive microvessels in advanced carotid lesions. Acta Neuropathologica. 116(5), pp.537-545.
MM. Turu, M. Slevin, S. Matou, D. West, C. Rodríguez, et al. A. Luque, M. Grau-Olivares, L. Badimon, J. Martinez-Gonzalez, J. Krupinski. (2008). C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biology. 9,
M. Slevin, P. Kumar, Q. Wang, S. Kumar, J. Gaffney, et al. M. Grau-Olivares, J. Krupinski. (2008). New VEGF antagonists as possible therapeutic agents in vascular disease. Expert Opin Investig Drugs. 17(9), pp.1301-1314.
PJ. García Ruiz, A. Sesar Ignacio, B. Ares Pensado, A. Castro García, F. Alonso Frech, et al. M. Alvarez López, J. Arbelo González, J. Baiges Octavio, JA. Burguera Hernández, M. Calopa Garriga, D. Campos Blanco, B. Castaño García, M. Carballo Cordero, J. Chacón Peña, A. Espino Ibáñez, A. Gorospe Onisalde, S. Giménez-Roldán, P. Granés Ibáñez, J. Hernández Vara, R. Ibáñez Alonso, FJ. Jiménez Jiménez, J. Krupinski, J. Kulisevsky Bojarsky, I. Legarda Ramírez, E. Lezcano García, JC. Martínez-Castrillo, D. Mateo González, F. Miquel Rodríguez, P. Mir, E. Muñoz Fargas, J. Obeso Inchausti, J. Olivares Romero, J. Olivé Plana, P. Otermin Vallejo, B. Pascual Sedano, V. Pérez de Colosía Rama, I. Pérez López-Fraile, A. Planas Comes, V. Puente Periz, MC. Rodríguez Oroz, D. Sevillano García, P. Solís Pérez, J. Suárez Muñoz, J. Vaamonde Gamo, C. Valero Merino, F. Valldeoriola Serra, JM. Velázquez Pérez, R. Yáñez Baña, I. Zamarbide Capdepon. (2008). Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord. 23(8), pp.1130-1136.
M. Slevin, P. Ethirajan, M. Molki, J. Gaffney, S. Kumar, et al. P. Kumar, J. Krupinski. (2008). Dynamin and perforin are associated with neovascularisation in advanced carotid plaques. Front Biosci. 13, pp.6515-6519.
M. Miguel Turu, J. Martínez González, A. Luque, A. Carvajal, JO. Juan-Babot, et al. MA. Font, E. Iborra, M. Slevin, F. Rubio, L. Badimón, J. Krupinski. (2008). Expression of C-reactive protein in atherosclerotic carotid plaques. Clinica e Investigacion en Arteriosclerosis. 20(3), pp.95-101.
M. Turu, M. Slevin, P. Ethirajan, A. Luque, A. Elasbali, et al. A. Font, J. Gaffney, M. Cairols, P. Kumar, S. Kumar, J. Krupinski. (2008). The normal cellular prion protein and its possible role in angiogenesis. Frontiers in Bioscience. 13(17), pp.6491-6500.
A. Luque, M. Turu, O. Juan-Babot, P. Cardona, A. Font, et al. A. Carvajal, M. Slevin, E. Iborra, F. Rubio, L. Badimon, J. Krupinski. (2008). Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques. Frontiers in Bioscience. 13(17), pp.6483-6490.
M. Turu, M. Slevin, S. Matou, C. RodrIguez, A. Luque, et al. L. Badimon, J. MartInez-Gonzalez, J. Krupinski. (2008). C-REACTIVE PROTEIN EXERTS POTENT ANGIOGENIC EFFECTS ON HUMAN VASCULAR ENDOTHELIAL CELLS. ATHEROSCLEROSIS SUPPLEMENTS. 9(1), pp.67-67.
J. Krupinski, A. Font, A. Luque, M. Turu, M. Slevin (2008). Angiogenesis and inflammation in carotid atherosclerosis. Frontiers in Bioscience. 13(17), pp.6472-6482.
J. Krupinski, MM. Turu, M. Slevin, J. Martínez-González (2008). Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke. Curr Cardiol Rep. 10(1), pp.25-30.
J. Krupinski, MM. Turu, MA. Font, E. Catena, M. Slevin, et al. S. Morchon, F. Rubio, L. Badimon, J. Martínez-González. (2008). Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: Results from a 1-year follow-up study. Cerebrovascular Diseases. 25(1-2), pp.32-39.
J. Montaner, P. Chacón, J. Krupinski, F. Rubio, M. Millán, et al. CA. Molina, P. Hereu, M. Quintana, J. Alvarez-Sabín. (2008). Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur J Neurol. 15(1), pp.82-90.
M. Slevin, Q. Wang, MA. Font, A. Luque, O. Juan-Babot, et al. J. Gaffney, P. Kumar, S. Kumar, L. Badimon, J. Krupinski. (2008). Atherothrombosis and plaque heterology: different location or a unique disease?. Pathobiology. 75(4), pp.209-225.
M. Slevin, J. Krupinski, N. Mitsios, C. Perikleous, E. Cuadrado, et al. J. Montaner, C. Sanfeliu, A. Luque, S. Kumar, P. Kumar, J. Gaffney. (2008). Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. Eur J Neurol. 15(1), pp.29-37.
M. Slevin, J. Krupinski, N. Mitsios, C. Perikleous, E. Cuadrado, et al. J. Montaner, C. Sanfeliu, A. Luque, S. Kumar, P. Kumar, J. Gaffney. (2008). Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. European Journal of Neurology. 15(1), pp.29-37.
M. Slevin, M. Grau-Olivares, J. Gaffney, P. Kumar, S. Hussain, et al. S. Kumar, J. Krupinski. (2007). Does cyclic dependent kinase 5 play a significant role in determination of stroke outcome? Possible therapeutic implications. Central Nervous System Agents in Medicinal Chemistry. 7(4), pp.251-258.
N. Mitsios, M. Saka, J. Krupinski, R. Pennucci, C. Sanfeliu, et al. Q. Wang, F. Rubio, J. Gaffney, P. Kumar, S. Kumar, M. Sullivan, M. Slevin. (2007). A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion. BMC Neurosci. 8,
J. Krupinski, MM. Turu, M. Slevin, J. Martínez-González (2007). Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke. Curr Treat Options Cardiovasc Med. 9(3), pp.229-235.
V. Cachofeiro (2007). Comentarios bibliográficos. Clínica e Investigación en Arteriosclerosis. 19(3), pp.154-155.
J. Krupinski, E. Catena, M. Miguel, P. Domenech, R. Vila, et al. S. Morchon, F. Rubio, M. Cairols, M. Slevin, L. Badimon. (2007). D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy. International Journal of Cardiology. 116(2), pp.174-179.
N. Mitsios, M. Saka, J. Krupinski, R. Pennucci, C. Sanfeliu, et al. M. Miguel Turu, J. Gaffney, P. Kumar, S. Kumar, M. Sullivan, M. Slevin. (2007). Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J Neurosci Res. 85(3), pp.602-611.
P. Cardona, F. Rubio, S. Martinez-Yélamos, J. Krupinski (2007). Endarterectomy, best medical treatment or both for stroke prevention in patients with asymptomatic carotid artery stenosis. Cerebrovasc Dis. 24 Suppl 1(Suppl. 1), pp.126-133.
N. Mitsios, J. Gaffney, J. Krupinski, R. Mathias, Q. Wang, et al. S. Hayward, F. Rubio, P. Kumar, S. Kumar, M. Slevin. (2007). Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue. Cell Biochem Biophys. 47(1), pp.73-86.
J. Krupinski, MM. Turu, MA. Font, N. Ahmed, M. Sullivan, et al. F. Rubio, L. Badimon, M. Slevin. (2007). Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. Vasc Health Risk Manag. 3(4), pp.405-412.
N. Mitsios, R. Pennucci, J. Krupinski, C. Sanfeliu, J. Gaffney, et al. P. Kumar, S. Kumar, O. Juan-Babot, M. Slevin. (2007). Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Brain Pathol. 17(1), pp.11-23.
M. Slevin, J. Krupinski, J. Gaffney, S. Matou, D. West, et al. H. Delisser, RC. Savani, S. Kumar. (2007). Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26(1), pp.58-68.
M. Slevin, P. Kumar, J. Gaffney, S. Kumar, J. Krupinski (2006). Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond). 111(3), pp.171-183.
N. Mitsios, R. Pennucci, J. Krupinski, C. Sanfeliu, J. Gaffney, et al. P. Kumar, S. Kumar, M. Slevin. (2006). Expression of cyclin-dependent kinase 5 and protein in the human brain following acute ischaemic stroke. EUROPEAN JOURNAL OF NEUROLOGY. 13, pp.51-51.
A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, et al. S. Kumar, P. Kumar, N. Mitsios, M. Slevin. (2006). Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain. 129(Pt 8), pp.2158-2176.
A. Al Qteishat, JJ. Gaffney, J. Krupinski, M. Slevin (2006). Hyaluronan expression following middle cerebral artery occlusion in the rat. Neuroreport. 17(11), pp.1111-1114.
MM. Turu, J. Krupinski, E. Catena, A. Rosell, J. Montaner, et al. F. Rubio, J. Alvarez-Sabin, M. Cairols, L. Badimon. (2006). Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis. 187(1), pp.161-169.
J. Krupinski, MM. Turu, J. Martinez-Gonzalez, A. Carvajal, JO. Juan-Babot, et al. E. Iborra, M. Slevin, F. Rubio, L. Badimon. (2006). Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke. 37(5), pp.1200-1204.
M. Slevin, AB. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, et al. J. Gaffney. (2006). Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol. 168(3), pp.1004-1021.
N. Mitsios, J. Gaffney, P. Kumar, J. Krupinski, S. Kumar, et al. M. Slevin. (2006). Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology. 73(4), pp.159-175.
PP. Cardona, AA. Escrig, MA. Font, J. Krupinski, FB. Rubio (2005). High altitude cerebral edema (HACE) and impaired vascular autoregulation. EUROPEAN JOURNAL OF NEUROLOGY. 12, pp.213-213.
J. Krupinski, M. Slevin, L. Badimon (2005). Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia. Neurochemical Research. 30(8), pp.1067-1073.
R. Issa, A. AlQteishat, N. Mitsios, M. Saka, J. Krupinski, et al. E. Tarkowski, J. Gaffney, M. Slevin, S. Kumar, P. Kumar. (2005). Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis. 8(1), pp.53-62.
M. Slevin, J. Krupinski, P. Kumar, J. Gaffney, S. Kumar (2005). Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection. J Cell Mol Med. 9(1), pp.85-102.
F. Rubio, S. Martínez-Yélamos, P. Cardona, J. Krupinski (2005). Carotid endarterectomy: is it still a gold standard?. Cerebrovasc Dis. 20 Suppl 2(Suppl. 2), pp.119-122.
M. Slevin, D. West, P. Kumar, P. Rooney, S. Kumar (2004). Hyaluronan, angiogenesis and malignant disease. Int J Cancer. 109(5), pp.793-794.
J. Krupinski, P. Stroemer, M. Slevin, E. Marti, P. Kumar, et al. F. Rubio. (2003). Three-dimensional structure and survival of newly formed blood vessels after focal cerebral ischemia. NeuroReport. 14(8), pp.1171-1176.
J. Bruna, I. Rojas-Marcos, S. Martínez-Yelamos, I. Català, A. Vidaller, et al. C. Galán, J. Krupinski, F. Rubio. (2003). Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder. J Neurooncol. 63(1), pp.63-67.
J. Krupinski, M. Slevin, E. Marti, E. Catena, F. Rubio, et al. J. Gaffney. (2003). Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats. Neuropathology and Applied Neurobiology. 29(2), pp.144-158.
E. Catena, J. Krupinski, R. Vila, MA. Cairols, F. Rubio-Borrego, et al. L. Badimón. (2003). Ateromatosis y aterotrombosis carotídea. Implicación del factor tisular. Angiología. 55(1), pp.64-76.
J. Krupinski, I. Ferrer, M. Barrachina, JJ. Secades, J. Mercadal, et al. R. Lozano. (2002). CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology. 42(6), pp.846-854.
I. Ferrer, B. Puig, J. Krupinsk, M. Carmona, R. Blanco (2001). Fas and Fas ligand expression in Alzheimer's disease. Acta Neuropathol. 102(2), pp.121-131.
I. Ferrer, J. Krupinski, E. Goutan, E. Martí, S. Ambrosio, et al. E. Arenas. (2001). Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol. 101(3), pp.229-238.
JA. Krupinski, EM. Puig, MA. Slevin, A. Slowik, A. Szczudlik (2001). Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. STROKE. 32(1), pp.355-355.
M. Slevin, J. Krupinski, A. Slowik, F. Rubio, A. Szczudlik, et al. J. Gaffney. (2000). Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport. 11(12), pp.2759-2764.
J. Krupinski, E. Lopez, E. Marti, I. Ferrer (2000). Expression of caspases and their substrates in the rat model of focal cerebral ischemia. Neurobiol Dis. 7(4), pp.332-342.
M. Slevin, J. Krupinski, A. Slowik, P. Kumar, A. Szczudlik, et al. J. Gaffney. (2000). Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 31(8), pp.1863-1870.
I. Ferrer, E. López, R. Blanco, R. Rivera, J. Krupinski, et al. E. Martí. (2000). Differential c-Fos and caspase expression following kainic acid excitotoxicity. Acta Neuropathol. 99(3), pp.245-256.
AJ. Strong, SE. Smith, DJ. Whittington, BS. Meldrum, AA. Parsons, et al. J. Krupinski, AJ. Hunter, S. Patel, C. Robertson. (2000). Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. Stroke. 31(1), pp.214-222.
B. Tomik, J. Krupinski, L. Glodzik-Sobanska, M. Bala-Slodowska, W. Wszolek, et al. M. Kusiak, A. Lechwacka. (1999). Acoustic analysis of dysarthria profile in ALS patients. J Neurol Sci. 169(1-2), pp.35-42.
A. Blann, P. Kumar, J. Krupinski, C. McCollum, DG. Beevers, et al. GYH. Lip. (1999). Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. BLOOD COAGULATION & FIBRINOLYSIS. 10(5), pp.277-284.
R. Issa, J. Krupinski, T. Bujny, S. Kumar, J. Kaluza, et al. P. Kumar. (1999). Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest. 79(4), pp.417-425.
R. Issa, J. Krupinski, T. Bujny, S. Kumar, J. Kaluza, et al. P. Kumar. (1998). Up-regulation of vascular endothelial growth factor (VEGF) mRNA, protein and its kinase insert domain receptor (VEGFR-2/KDR) in human brain tissue following ischaemic stroke. JOURNAL OF VASCULAR RESEARCH. 35(5), pp.379-379.
M. Slevin, J. Krupinski, S. Kumar, J. Gaffney (1998). Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest. 78(8), pp.987-1003.
J. Krupiński, MA. Slevin, P. Kumar, J. Gaffney, J. Kałuza (1998). Protein kinase C expression and activity in the human brain after ischaemic stroke. Acta Neurobiol Exp (Wars). 58(1), pp.13-21.
J. Krupinski, Y. Vodovotz, CG. Li, A. Slowik, D. Beevers, et al. KC. Flanders, G. Lip, P. Kumar, A. Szczudlik. (1998). Inducible nitric oxide production and expression of transforming growth factor-beta 1 in serum and CSF after cerebral ischaemic stroke in man. NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 2(6), pp.442-453.
J. Krupinski, R. Issa, T. Bujny, M. Slevin, P. Kumar, et al. S. Kumar, J. Kaluza. (1997). A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke. 28(3), pp.564-573.
J. Krupinski, J. Kaluza, P. Kumar, S. Kumar (1996). Immunocytochemical studies of cellular reaction in human ischemic brain stroke. MAB anti-CD68 stains macrophages, astrocytes and microglial cells in infarcted area. Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 34(1), pp.17-24.
J. Krupinski, P. Kumar, S. Kumar, J. Kaluza (1996). Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke. 27(5), pp.852-857.
J. Krupiński, J. Kałuza, P. Kumar, S. Kumar (1996). Immunocytochemical studies of cellular reaction in human ischemic brain stroke. MAB anti-CD68 stains macrophages, astrocytes and microglial cells in infarcted area. Folia Neuropathologica. 34(1), pp.16-24.
J. Krupinski, J. Kaluza, P. Kumar, S. Kumar (1996). Immunocytochemical studies of cellular reaction in human ischemic brain stroke. MAB anti-CD68 stains macrophages, astrocytes and microglial cells in infarcted area. FOLIA NEUROPATHOLOGICA. 34(1), pp.17-24.
J. KRUPINSKI, J. KALUZA, P. KUMAR, S. KUMAR, JM. WANG (1994). ROLE OF ANGIOGENESIS IN PATIENTS WITH CEREBRAL ISCHEMIC STROKE. STROKE. 25(9), pp.1794-1798.
J. KALUZA, J. KRUPINSKI, P. KUMAR, S. KUMAR, JM. WANG (1994). VCAM-1 EXPRESSION ON REACTIVE AND TUMOR ASTROCYTES. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA. 32(1), pp.17-20.
J. KRUPINSKI, J. KALUZA, P. KUMAR, M. WANG, S. KUMAR (1993). PROGNOSTIC VALUE OF BLOOD-VESSEL DENSITY IN ISCHEMIC STROKE. LANCET. 342(8873), pp.742-742.
JM. Wang, S. Kumar, D. Pye, AJ. van Agthoven, J. Krupinski, et al. RD. Hunter. (1993). A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer. 54(3), pp.363-370.
J. Krupiński, J. Kałuza, P. Kumar, S. Kumar, JM. Wang (1993). Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol Pol. 44(4), pp.203-209.
N. Cullell, J. González-Sánchez, I. Fernández-Cadenas, J. Krupinski (2020). Generation and Applicability of Genetic Risk Scores (GRS) in Stroke. In: Neuromethods. Springer New York, pp.23-34.
J. Krupinski, J. de Francisco, S. Huertas (2014). Detection and Management of Atrial Fibrillation in Patients with Stroke or TIA in Clinical Practice. In: Cardiac Arrhythmias. Springer London, pp.221-236.
A. Arboix, M. Grau-Olivares, J. Krupinski (2010). Vascular Development, Stroke and Neurodegenerative Disease: A Place for Novel Clinical Interventions?. In: Therapeutic Angiogenesis for Vascular Diseases. Springer Netherlands, pp.313-338.
N. Cullell, C. Gallego-Fábrega, J. Cárcel, E. Muiño, L. Llucià-Carol, et al. M. Lledós, R. Beal, S. White, M. Esteller, M. Castro de Moura, J. Krupinski, I. Fernández-Cadenas. (2021). BS4 Modelling of stroke risk: an epigenetic and in vitro study. In: Basic science. pp.A157-A157.
A. Flores, L. Sero, X. Ustrell, A. Pellise, M. Gomez Choco, et al. J. Vinas, E. Palomeras, J. Krupinski, N. Mas, D. Cocho, F. Purroy, J. Zaragoza-brunet, P. Cardona, J. Serena, M. Ribo, V. Obach, M. Rubiera, N. Perez de la Ossa. (2021). The Role of Vascular Imaging at Primary Stroke Centers in the Drip and Ship Paradigm. In: STROKE.
X. Urra, A. Renu, M. Gomis, N. Mas, M. Gomez-Choco, et al. F. Purroy, J. Serena, J. Marti Fabregas, P. Cardona, C. Molina, J. Roquer, D. Canovas, J. Krupinski, X. Ustrell, RM. Vivanco-Hidalgo, S. Abilleira, A. Chamorro. (2020). UNRAVELING PROGNOSTIC FACTORS VS. TREATMENT EFFECT MODIFIERS IN A POPULATION-BASED COHORT OF LARGE VESSEL STROKE PATIENTS WITH AND WITHOUT ACUTE REVASCULARIZATION. In: INTERNATIONAL JOURNAL OF STROKE. pp.54-55.
RM. Vivanco-Hidalgo, M. Boher, S. Abilleira, A. Ribera, S. Rudilosso, et al. L. Sero, F. Purroy, N. Mas, P. Cardona, C. Molina, J. Krupinski, J. Serena Leal, J. Zaragoza, J. Marti Fabregas, M. Gomez-Choco, D. Canovas, M. Gomis, A. Rodriguez Campello, L. Martinez, N. Perez De La Ossa, R. Roman. (2020). VALIDATION OF A PREDICTIVE MODEL FOR MORTALITY IN ISCHEMIC STROKE USING MACHINE LEARNING IN A POPULATION-BASED SETTING. In: INTERNATIONAL JOURNAL OF STROKE. pp.446-446.
J. Carcel-Marquez, NP. Torres-Aguila, E. Muino, C. Carrera, N. Cullell, et al. C. Gallego Fabrega, J. Jimenez-Conde, P. Camps-Renom, L. Prats-Sanchez, J. Montaner, J. Krupinski, J. Marti-Fabregas, I. Fernandez-Cadenas. (2020). AN INTEGROMIC ANALYSIS FINDS NEW GENES ASSOCIATED WITH LACUNAR STROKE RISK. In: INTERNATIONAL JOURNAL OF STROKE. pp.74-74.
E. Muino, O. Maisterra, J. Jimenez-Balado, N. Cullell, C. Carrera, et al. N. Torres, J. Carcel-Marquez, C. Gallego Fabrega, J. Gonzalez Sanchez, F. Olmos-Alpiste, E. Espejo, A. March, R. Pujol, A. Rodriguez Campello, G. Romeral, J. Krupinski, J. Marti Fabregas, J. Montaner, J. Roquer, I. Fernandez-Cadenas. (2020). GENOME-WIDE TRANSCRIPTOME STUDY IN SKIN BIOPSIES REVEALS AN ASSOCIATION OF E2F4 WITH CADASIL AND COGNITIVE IMPAIRMENT. In: INTERNATIONAL JOURNAL OF STROKE. pp.73-74.
C. Gallego Fabrega, N. Cullell, E. Muino, J. Carcel-Marquez, J. Carcel, et al. U. Lazcano, C. Carrera, N. Torres, P. Camps-Renom, L. Prats-Sanchez, E. Jimenez-Xarrie, J. Jimenez-Conde, J. Roquer, J. Montaner, J. Krupinski, J. Marti-Fabregas, I. Fernandez. (2020). EPIGENETIC BIOLOGICAL AGE MIGHT EXPLAIN AGE DIFFERENCES BETWEEN SEXES AT STROKE ONSET. In: INTERNATIONAL JOURNAL OF STROKE. pp.87-88.
N. Cullell, C. Soriano-Tarraga, C. Gallego-Fabrega, J. Carcel-Marquez, C. Carrera, et al. NP. Torres-Aguila, E. Muino, M. Esteller, M. Castro De Moura, J. Montaner, R. Elosua, A. Fernandez-Sanles, J. Marti-Fabregas, J. Krupinski, J. Roquer, J. Jimenez-Conde, I. Fernandez-Cadenas. (2020). EPIGENOME-WIDE ASSOCIATION STUDY AND MENDELIAN RANDOMIZATION IN ISCHEMIC STROKE RISK. In: INTERNATIONAL JOURNAL OF STROKE. pp.95-95.
Y. Silva Blas, S. Abilleira, L. Sanchez-Cirera, L. Munoz-Narbona, M. Ribo, et al. P. Cardona, L. Llull, J. Roquer, J. Marti-Fabregas, S. Garcia-Sanchez, X. Ustrell, F. Purroy, J. Zaragoza, D. Canovas, J. Krupinski, N. Mas, E. Palomeras, D. Cocho, N. Lopez, E. Sanjurjo, D. Carrion, M. Lopez, MC. Almendros, M. Barcelo, J. Monedero, E. Catena, L. Redondo, M. Rybyeba, G. Diaz, N. Perez De La Ossa. (2020). SEX DIFFERENCES IN ACUTE STROKE CARE, METRICS, ACCESS TO TREATMENT AND OUTCOME: A TERRITORIAL ANALYSIS OF THE STROKE CODE SYSTEM OF CATALONIA. In: INTERNATIONAL JOURNAL OF STROKE. pp.752-752.
L. Dorado, N. Perez de la Ossa, S. Abilleira, P. Cardona, E. Giralt, et al. X. Urra, M. Ribo, D. Canovas, M. Garces, J. Krupinski, J. Marti-Fabregas, A. Pellise, F. Purroy, J. Saura, J. Serena, C. Molina, A. Davalos, M. Gallofre. (2016). Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia. In: STROKE. Los Angeles, CA, 17/2/2016.
M. Angels Font, I. Rico, A. Fernandez, J. Mora, A. Carvajal, et al. L. Rodriguez, C. Gamez, A. Luque, L. Badimon, J. Krupinski. (2011). Effects Of Carotid Endarterectomy On Brain Cognition, Metabolism And Perfusion. In: STROKE. Los Angeles, CA, 8/2/2011. pp.E182-E182.
A. Bosutti, S. Matou, J. Qi, R. Pennucci, L-H. Tsai, et al. KP. Giese, S. Love, J. Krupinski, S. Kumar, M. Slevin. (2011). Over-Expression Of Cyclin-Dependent Kinase 5 Stimulates Cell Migration But Not Cell Differentiation In Human Brain Microvascular Endothelial Cells. In: STROKE. Los Angeles, CA, 8/2/2011. pp.E134-E134.
A. Luque, MM. Turu, M. Slevin, JO. Juan-Babot, N. Rovira, et al. A. Carvajal, MA. Font, J. Krupinski. (2011). Chlamydia Pneumoniae In Early Lesions Of Patients With Carotid Atherosclerosis. In: STROKE. Los Angeles, CA, 8/2/2011. pp.E189-E189.
M. Mendioroz, I. Fernandez-Cadenas, A. Arboix, E. Palomeras, M. Freijoo, et al. M. Ribo, D. Salat, D. Canovas, M. Grau, J. Krupinski, M. Angels Font, F. Rubio, J. Arenillas, A. Davalos, M. Martinez-Zabaleta, J. Masjuan, C. Pinana, P. Moniche, J. Serena, F. Purroy, J. Marti, J. Roquer, C. Tejero, N. Aymerich, J. Fernandez-Morales, D. Giralt, A. Del-Rio, J. Alvarez-Sabin, J. Montaner, S. Domingues-Montanari. (2010). Genotyping Recurrence Of Stroke (GRECOS) Project: Two Genes Involved in Hypoxia Responses and Blood Brain Barrier Function Are Associated With Vascular Recurrence in a Preliminary Study. In: STROKE. San Antonio, TX, 23/2/2010. pp.E334-E335.
I. Rico, M. Angels Font, A. Carvajal, M. Juncadella, J. Mora, et al. M. Cairols, J. Krupinski. (2010). Increase in Cerebral Perfusion on 99mTc-HMPAO Spect in Patients Following Asymptomatic Carotid Endarterectomy Does Not Mean Better Cognitive Performance. In: STROKE. San Antonio, TX, 23/2/2010. pp.E324-E325.
M. Angels Font, I. Rico, A. Fernandez, C. Gamez, J. Krupinski (2010). Cerebral Metabolism Measured by 18-FDG-PET Improves Over Time in Patients Following Carotid Endarterectomy. In: STROKE. San Antonio, TX, 23/2/2010. pp.E250-E250.
A. Bosutti, R. Pennucci, S. Matou, J. Gaffney, S. Love, et al. L-H. Tsai, KP. Giese, S. Kumar, J. Krupinski, M. Slevin. (2010). Alterations in Cyclin-dependent Kinase 5 Activator p35 Signaling Are Associated With Angiogenesis, in Brain Endothelial Cells. In: STROKE. San Antonio, TX, 23/2/2010. pp.E350-E350.
A. Bosutti, R. Pennucci, J. Krupinski, S. Kumar, P. Kumar, et al. M. Slevin. (2009). Involvement Of The Cyclin-dependent Kinase 5 In Microvascular Endothelial Cell Migration In Vitro. In: STROKE. San Diego, CA, 17/2/2009. pp.E141-E141.
A. Luque, MM. Turu, O. Juan-Babot, A. Carvajal, MA. Font, et al. M. Slevin, L. Badimon, J. Krupinski. (2009). Chlamydia Pneumoniae Infection Appears In A Very Early Carotid Lesions And Is Associated With Important Immune Responses. In: STROKE. San Diego, CA, 17/2/2009. pp.E184-E185.
R. Pluvinet, R. Olivar, J. Krupinski, L. Sumoy, JM. Aran (2008). A global gene expression profiling analysis to study the role of endothelial CD40 during inflammation. In: INFLAMMATION RESEARCH. Chantilly, VA, 21/9/2008. pp.S103-S104.
J. Krupinski, MM. Turu, S. Matou, C. Rodriguez, J. Martinez-Gonzalez, et al. L. Badimon, A. Luque, M. Slevin. (2008). C-reactive protein exerts potent angiogenic effects on vascular endothelial cells. In: STROKE. New Orleans, LA, 19/2/2008. pp.566-566.
MA. Font, A. Fernandez, C. Gamez, M. Slevin, R. Vila, et al. E. Iborra, F. Rubio, J. Krupinski. (2008). (18)FDG-PET imaging of human carotid arteries prior to endarterectomy confirms it is a bilateral disease. In: STROKE. New Orleans, LA, 19/2/2008. pp.564-564.
N. Mitsios, M. Saka, J. Krupinski, R. Pennucci, C. Sanfeliu, et al. J. Gaffney, P. Kumar, S. Kumar, M. Slevin. (2007). A comparison of gene and protein regulation changes between human and a rat model of stroke using cDNA microarrays. In: JOURNAL OF NEUROCHEMISTRY. Cancun, MEXICO, 19/8/2007. pp.265-265.
P. Ethirajan, J. Gaffney, P. Kumar, J. Krupinski, M. Slevin (2007). Increased PRPC expression in human carotid artery lesions. In: ATHEROSCLEROSIS SUPPLEMENTS. Helsinki, FINLAND, 10/6/2007. pp.213-213.
M. Slevin, P. Ethirajan, P. Kumar, J. Gaffney, A. Elasbali, et al. J. Krupinski, MM. Turu. (2007). Prion protein is over-expressed in intimal neovessels of complicated carotid plaques. In: FASEB JOURNAL. Washington, DC, 28/4/2007. pp.A854-A854.
J. Krupinski, P. Ethirajan, MM. Turu, A. Elasbali, MA. Font, et al. J. Gaffney, F. Rubio, M. Slevin. (2007). Normal prion protein involvement in angiogenic switch in human carotid artery plaques. In: STROKE. San Francisco, CA, 7/2/2007. pp.568-568.
MA. Font, A. Fernandez, MM. Turu, C. Gamez, M. Slevin, et al. F. Rubio, L. Badimon, J. Krupinski. (2007). Metabolic proinflammatory activity in human carotid artery plaques is detected by (18)FDG-PET imaging prior to endarterectomy. In: STROKE. San Francisco, CA, 7/2/2007. pp.587-587.
N. Mitsios, R. Pennucci, J. Krupinski, C. Sanfeliu, J. Gaffney, et al. P. Kumar, S. Kumar, M. Slevin. (2006). Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. In: FASEB JOURNAL. San Francisco, CA, 1/4/2006. pp.A461-A461.
LG. Mera, AE. Avellaneda, J. Krupinski, MJ. de Evan, FR. Borrego (2004). Coexistence of dural arteriovenous fistulae and factor V Leiden mutation. In: JOURNAL OF NEUROLOGY. Barcelona, SPAIN, 26/6/2004. pp.136-136.
J. Montaner, P. Chacon, J. Krupinski, F. Rubio, M. Millan, et al. D. Escudero, P. Hereu, C. Molina, M. Quintana, J. Alvarez-Sabin. (2004). Safety and efficacy of statins in the acute phase of ischemic stroke: the MISTICS trial. In: STROKE. SAN DIEGO, CA, 5/2/2004. pp.293-293.